regulatory

News

Flood of warning letters follows DTC ad clampdown

The FDA has lost no time following through on its plan to tighten up DTC advertising of medicines, sending out dozens of untitled and warning letters.

News

FDA's Makary explains 'overdue' pharma ads crackdown

FDA Commissioner Marty Makary has called DTC ads for medicines a "public health crisis" as the industry prepares for a regulatory crackdown.

News

RFK Jr expands ACIP ahead of highly anticipated meeting

Five members have been added to a controversial CDC vaccines panel ahead of a meeting this week that could have an impact on US immunisation policy.

News

Intercept pulls Ocaliva off the market in the US

Alfasigma's $800m buyout of Intercept is starting to look like a poor bet as its only product, Ocaliva, is pulled from the market.

News

Pharma says UK is 'tumbling down' rankings for investment

The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects, says a report from the ABPI pharma group.

News

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

The FDA has set up a green list of overseas sources for GLP-1 ingredients to try to block imports of illegitimate and potentially unsafe materials.

Flood of warning letters follows DTC ad clampdown

FDA's Makary explains 'overdue' pharma ads crackdown

RFK Jr expands ACIP ahead of highly anticipated meeting

Intercept pulls Ocaliva off the market in the US

Pharma says UK is 'tumbling down' rankings for investment

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

regulatory

Editor's Picks